The Kansas City Chiefs are moving to Kansas. The Chiefs, in conjunction with Kansas Gov. Laura Kelly and NFL commissioner Roger Goodell, announced in a statement from owner and chairman Clark Hunt on ...

Plans to transform an old campground near Lake Tahoe into a modern, resort-style destination have been approved. The Placer County site sits just off Interstate 80 near the small unincorporated ...

MADISON — In a game where both defenses stood out, it was a special teams play that decided the D1 state championship. A 76-year-yard kickoff return for a touchdown in the final minute of play ...

FDA approved Plozasiran (now REDEMPLO™) on November 18, 2025, for reducing triglycerides in adults with FCS, the first siRNA therapy for this rare disease. ARWR boasts a diversified RNAi pipeline ...

With a fresh FDA endorsement for its drug plozasiran, California-based Arrowhead Pharmaceuticals has successfully broken through to the commercial realm. Complicating the matter, however, is the fact ...

The Kansas City Chiefs have been one of the NFL’s most dominant teams of the last decade, winning three Super Bowl championships and playing in seven straight AFC Championship games. And while the ...

Arrowhead High School's football team advanced to the Division 1 state semifinals for the first time since 2015. The Warhawks overcame a 21-0 deficit to defeat Sussex Hamilton 34-24. A strong ...

Arrowhead Pharmaceuticals has seen its consensus analyst price target increase from $45 to $47.50 per share, reflecting growing confidence in the company's strategy and market positioning. This ...

KANSAS CITY, Mo. — FOX4 has confirmed that local architecture firm Populous updated its proposed renovation plans for GEHA Field at Arrowhead Stadium, as the Chiefs consider options for their future ...

Arrowhead, ranked No. 1 in High School on SI Wisconsin's Top 25, remains undefeated with a 3-0 overall record. The reigning Classic 8 Conference co-champion Warhawks have combined to outscore their ...

PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that yesterday it filed a Complaint for Declaratory Judgment in the United States District Court for ...